Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$63.83 - $80.0 $99,383 - $124,560
-1,557 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$76.85 - $89.45 $19,596 - $22,809
-255 Reduced 14.07%
1,557 $121,000
Q4 2021

Jan 19, 2022

BUY
$74.57 - $87.19 $28,784 - $33,655
386 Added 27.07%
1,812 $156,000
Q3 2021

Oct 14, 2021

BUY
$73.77 - $83.61 $28,991 - $32,858
393 Added 38.04%
1,426 $115,000
Q2 2021

Jul 19, 2021

BUY
$80.5 - $88.01 $4,427 - $4,840
55 Added 5.62%
1,033 $83,000
Q1 2021

Apr 28, 2021

SELL
$76.38 - $86.03 $35,134 - $39,573
-460 Reduced 31.99%
978 $82,000
Q4 2020

Jan 22, 2021

BUY
$75.39 - $82.36 $83,682 - $91,419
1,110 Added 338.41%
1,438 $115,000
Q3 2020

Oct 20, 2020

BUY
$78.33 - $90.73 $25,692 - $29,759
328 New
328 $26,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.